Medtronic Message Board


hugo robotic surgery system

4 hours ago

The pictures from that tweet were taken down on Twitter. Did anyone screenshot it or save them ? Verb's device looked sick.

Medtronic Robotic Surgery Platform

2 weeks ago

More info will be provided at the analysts day on Sept. 24 which will be focused on Medtronic's robotic surgical systems. A new soft-tissue robot, specifically.

FDA Grants Fast Track Designation for FARXIGA in Heart Failure

13 hours ago

AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of FARXIGA (dapagliflozin) to reduce the risk of cardiovascular (CV) death or the worsening of heart failure in adults with heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF).

Medtronic Benefits

2 weeks ago

I guess that means Medtronic has some pretty darn good insurance benefits?

Intact Vascular to Announce One-Year Data from TOBA III Clinical Trial

13 hours ago

​Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that the one-year data from its Tack Optimized Balloon Angioplasty (TOBA) III clinical trial will be presented during the High Impact Clinical Research session of the 31st

Medtronic CEO Compensation

3 weeks ago

The company is about to spend a lot less on CEO compensation because Omar is retiring next year.

As much grief as he gets on this board, he is a very good CEO and this is seemingly out of the blue. Medtronic will be worse off for him leaving.

Pour out a 40 for him this weekend.

Medtronic Stock

4 weeks ago

FDA approves lower risk patients for TAVR surgery. Another positive for Medtronic and our stock. Up, up, and away!!

Medtronic Evolut Deaths

4 weeks ago

Big news last week with the FDA approving TAVR for lower risk patients. Cardiothoracic Surgeons have to be fuming!!

National Lipid Association’s New Position Statement on Use of Icosapent Ethyl in High and Very-High-Risk Patients Recognizes Importance of Addressing Residual Cardiovascular Risk in Patients on Statins

14 hours ago

​Amarin Corporation plc (NASDAQ: AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced that the National Lipid Association (NLA) has issued a position statement recognizing the cardiovascular risk-lowering effects of icosapent ethyl based on the landmark REDUCE-IT cardiovascular outcomes study.

Flowonix vs Medtronic

2 months ago

Damn these posts reeks of Flowonix executives on Medtechy pushing their shitty product.

Flowonix don't even publish their adverse reactions in the Maude database. They are as sketchy as you can get. Should we talk about how they believed they were MRI compatible and killed patients in the machine before they changed their labelling?

IN.PACT Admiral FDA Alert

1 month ago

The FDA just eased up on Paclitaxel Device recommendations, so yes, much to do about nothing.

Stealth Station Recalls

1 month ago

I didn’t know Medtronic still sold StealthStations. No one in my territory uses one.

Celgene Announces Phase 3 QUAZAR AML-001 Study of CC-486 as Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Met Primary and Key Secondary Endpoints

3 days ago

Celgene Corporation (NASDAQ: CELG) today announced top-line results from the international phase 3, randomized, double-blind, placebo-controlled study, QUAZAR AML-001. The study evaluated the efficacy and safety of investigational therapy CC-486 as maintenance therapy in patients with newly diagnosed acute myeloid leukemia (AML)

Medtronic Integrated Health Solutions

1 month ago

Frontline sales reps are a dying breed in the industry. Be a corporate rep or specialist of some kind.

Medtronic Getting Into Artificial Intelligence

1 month ago

Hopefully Medtronic's AI pursuits come to fruition faster that their robotic program has. Medtronic signed a distribution agreement with Viz.ai, which uses AI technology to streamline stroke care.


Viz.ai's artificial intelligence-powered imaging software is aimed at quickly treating patients suspected of having ischemic strokes. Viz.ai, based in San Francisco, received FDA’s de novo clearance for its clinical decision support software for stroke back in February 2018. The company is pursuing r…

Loading...